Keywords: data, finds, rise, serious, ae, reports, fda
US data finds 38% rise in serious AE reports to FDA; Chantix claims disputed
Article | 03 November 2008
US data compiled by the Pennsylvania-located Institute for Safe Medication Practices, which was based on Food and Drug Administration figures, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
